SUMMARY
erties of facilitation and tetanic potentiation. The effect increases synaptiq, efficacy and antagonizes the depressant effect of pressure on singly evoked responses. Enhancement of synaptic potentiation is therefore a possible mechanism of pressure reversal of anaesthesia or of the seizures associated with high pressure.
The present study was designed with two Excitatory junctional potentials (EJP) were amplified, digitized (Scientific Solutions Labmaster) and stored on disc for later analysis by microcomputer-based software (pClamp, Axon Instruments). Singly evoked EJP analysed for amplitude and temporal properties are averages of 15 individual responses, as are paired responses analysed for facilitation. Responses to trains of stimuli are not averaged. Illustrations of EJP were generated from the digitized records and plotted on an H-P 7470A plotter. Membrane resistance was measured and current-voltage curves obtained by injecting current through the recording microelectrode and monitoring the resultant changes in voltage.
After control records were obtained, the preparation was perfused with solution containing one of the three anaesthetic agents. Pentobarbitone was dissolved in solution to achieve a concentration of 1-5 x 10" 4 mol litre" 1 , a range of concentrations which brackets the anaesthetic dose for this agent. Methoxyflurane and halothane were mixed with oxygen by calibrated vaporizers in concentrations of 0.1-0.4% v/v (methoxyflurane) and 0.5-3.0% v/v (halothane); these concentrations range from slightly below to well above the clinical anaesthetic range. The perfusing solution was equilibrated with the gas mixture by bubbling for at least 30 min. Records of the anaesthetic effect were made 20-30 min after perfusion had begun with a given concentration of the agent, when the effects were at a steady state. Reversibility was assessed by washing with drug-free solution. Twelve experiments at normobaric pressure were undertaken with pentobarbitone, five with halothane, and five with methoxyflurane. Pentobarbitone was the agent used in all pressure studies. For pressure experiments, the preparation was mounted for intracellular recording as described above, placed in a pressure chamber, and perfused continuously with oxygenated Ringer's solution. Control recordings were made after the chamber was sealed. Pressure was applied by admitting helium from a high-pressure cylinder. Details of the pressure chamber, com- pression regimens and temperature control were as described previously [26] . Measurements at pressure were made 20 min or more after the compression step. Sixteen experiments were completed in which both pressure and pentobarbitone were applied to the same preparation. In five of these, control measurements were made, the preparation was compressed to 10.1 MPa, the effect of pressure determined, and pentobarbitone applied at pressure. In the remainder, the effects of pentobarbitone at 0.1 MPa were determined and the preparation then compressed to 10.1 MPa. Additional experiments were undertaken with pressure alone. Comparisons were made between the effects of pentobarbitone at normal pressure and at 10.1 MPa, and between the effects of pressure with and without pentobarbitone. Data were analysed by ANOVA to reveal anaesthetic interaction with pressure effects and vice versa; in addition t tests for paired values were carried out in those cases in which the data were obtained from the same preparation.
RESULTS

Sensitivity of the junction to anaesthetics
Preliminary experiments were carried out to confirm the sensitivity of the glutaminergic excitatory junction to clinically relevant anaesthetic concentrations. Examples of the depressant effects of pentobarbitone, halothane and methoxyflurane are shown in figure 2. Synaptic dose-response curves were not constructed; however, the lowest concentration of pentobarbitone, 10" 4 mol litre" 1 , depressed EJP amplitude by at least 20 % and the highest, 5 x 10" 4 mol litre" 1 , by at least 75%. Halothane 0.5-1 % depressed responses by at least 20%; 1.5% by at least 75%. Methoxyflurane 0.1% depressed responses by at least 20%; concentrations greater than 0.2% nearly abolished the response. The effects of the anaesthetics on amplitude and time course of the excitatory junctional potential (EJP) are shown quantitatively in figure 3 . The depression of the EJP amplitude and rate of increase (d V/dt) were significant for all three agents (P < 0.05). The decay rate of the EJP was of particular interest as a potential measure of pressure-anaesthetic antagonism, since pressure prolongs the declining phase of the EJP [24] . Although pentobarbitone appeared to increase the rate of decay in some preparations, the effect was not significant. There were no apparent effects of halothane or methoxyflurane on decay half-time ( fig. 3) . None of the anaesthetics significantly or consistently altered muscle resting potential or resistance as measured by the current/voltage relationship.
In each preparation, a single anaesthetic concentration was chosen at which other synaptic properties were measured, using the criterion of a mid-range depression of singly evoked EJP amplitude. Amplitudes of the anaesthetic-depressed EJP at concentrations at which the properties of facilitation and potentiation were measured were 47.9 % ± 11 (SD) of control (drug-free) values for 4 mol litre" 1 on tetanic potentiation at normal pressure. Control (top) and pentobarbitone-depressed (middle) responses to a train of stimuli at 70Hz, plotted to the same scale. Below, the pentobarbitone-depressed response scaled upward so that the first EJP of the train matches the control amplitude, and superimposed on the latter. Potentiation increased markedly in the presence of pentobarbitone.
halothane, 33.2% ±5 for methoxyflurane, and 62.7% ± 18 for pentobarbitone.
Activity-dependent pressure reversal of anaesthetic synaptic depression
We used repetitive trains of stimuli to test if pressure enhancement of tetanic potentiation antagonized pentobarbitone-induced synaptic depression. The pattern consisted of a train 0.9 s long, stimulus frequency within the train 60-90 Hz, repeated five times at a train repetition rate of 0.5 Hz. Repetitive stimulation at 10.1 MPa increased the pentobarbitone-depressed response above the comparable normobaric level (fig. 4) . The result was a partial reversal of pentobarbitone-induced synaptic depression. Peak and mean levels of depolarization were greater at 10.1 MPa than at normal pressure in the presence of pentobarbitone. This is the first time pressure reversal of anaesthetic effects has been demonstrated at a synapse.
Is the reversal a pressure-anaesthetic antagonism ?
Pressure reversal of anaesthetic effects on synaptic transmission through enhancement of tetanic potentiation might represent direct antagonism if anaesthetic agents depressed synaptic potentiation. Our results did not support this possibility. Pentobarbitone enhanced the build up of tetanic potentiation at normobaric pressure ( fig. 5 ), thus antagonizing its own depressant effects in an activity-dependent fashion. Potentiation was quantified by measuring the amplitude from baseline of the last response in a 0.9-s train relative to the first; stimulus frequency within the train was 40-90 Hz. Pentobarbitone was associated with a mean increase in potentiation of approximately 25% in eight experiments; this effect was significant (P < 0.01).
A series of experiments was carried out to test if volatile agents behaved differently from barbiturates in this respect. Neither halothane nor methoxyflurane decreased potentiation. Thus for the volatile agents, in addition to pentobarbitone, there was no evidence for pressure-anaesthetic antagonism.
Paired-pulse facilitation
Potentiation as measured in this study included summation, the short-term process of facilitation, and one or more longer term processes. Our previous studies [24] showed that pressure significantly enhanced the facilitation evoked by paired stimuli to the excitor motor neurone. Experiments were carried out to test if anaesthetics antagonized the effect of pressure on facilitation. The effect of pressure on paired-pulse facilitation was maximal at an interpulse interval of 10 ms; accordingly, this interval was chosen to examine the effects of anaesthetics. At this short interval a portion of the enhancement of the response to the second stimulus resulted from summation. Data were analysed with this component included (facilitation + summation) and with the summation component subtracted digit- ally as shown in figure 6 , to give a measure of facilitation alone. The effects of halothane, methoxyflurane and pentobarbitone on facilitation + summation and on facilitation alone are shown graphically in figure 7 . No agent depressed each measure of paired-pulse facilitation. For pentobarbitone and halothane, but not methoxyflurane, there was a consistent enhancement of the values for facilitation, but this was too small to be significant.
The role of inhibition
Barbiturate enhancement of GABA-mediated inhibition has often been observed. In this crustacean preparation, the single GABA-ergic inhibitory motor neurone can exert marked depressant effects on the excitatory response. Since the reversal potential for the inhibitory junctional potential (IJP) is close to the normal resting potential, normally the IJP is small or undetectable. Inhibition is therefore monitored most easily by effects on the EJP. An example of inhibition is shown in figure 8 . At normobaric pressure pentobarbitone did not significantly affect inhibition in this preparation, measured as a decrease in EJP amplitude or an increase in EJP rate of decay. Pressure depressed inhibition of the EJP to the same extent as pressure depressed the EJP itself [24] . Pentobarbitone did not prevent or reverse the non-selective decrease in inhibition observed on compression to 10.1 MPa (fig. 8) .
When the inhibitor was stimulated concurrently with the excitor during a train, the result was inhibition of all the EJP in the train. Because the inhibitory junction also displayed potentiation, the developing inhibition limited the extent of potentiation shown by the excitor. Pentobarbitone did not significantly modify inhibition during a train of stimuli, either at normal or at hyperbaric pressure ( fig. 9 ). In this preparation, enhancement of inhibition by the anaesthetic did not contribute to overall depression of excitatory transmission. Selective depression of inhibitory transmission by pressure did not contribute to reversal of the anaesthetic effect.
True antagonism} There appears to be no evidence that pressure and anaesthetics acted antagonistically at this synapse. Both depressed the singly evoked EJP and both enhanced potentiation. Pentobarbitone effects on inhibition did not contribute to anaesthetic depression of the EJP; pressure effects on inhibition did not contribute to activity-dependent pressure reversal of anaesthetic depression. It remains to ask if any "true" antagonism between anaesthetics and pressure exists which is only revealed when both are applied together. Are the effects of pressure different in the presence of the anaesthetic, and vice versa ? This did not appear to be the case. The pressure at which pentobarbitone was applied did not modify significantly the depressant effect of pentobarbitone on the EJP, and the presence of pentobarbitone did not significantly change the depressant effect of pressure. There was also no interaction on inhibition. The results of both interactions are presented graphically in figure 9 . With respect to EJP amplitude and inhibition, therefore, there was no obvious "true" pressure-anaesthetic antagonism that appeared only when the two interventions were applied together. The effects of pressure on facilitation were also not modified by the presence of pentobarbitone.
DISCUSSION
Fundamental effects of the anaesthetics
All the agents significantly depressed the amplitude and rate of rise of the singly evoked EJP at clinically relevant anaesthetic concentrations. Anaesthetic partial pressures (minimal alveolar concentrations, MAC) in man are 0.75-0.77% halothane and 0.16% methoxyflurane. Anaesthetic blood: water values for pentobarbitone are reported in the range 1-6 x 10" 4 mol litre" 1 [27, 28] . At this glutaminergic "synapse" in Crustacea, therefore, there was a significant depressant effect at anaesthetic concentrations, to an extent similar to that observed at many other excitatory synapses. However, other reports have suggested that crustacean neuromuscular junctions are less sensitive to the effects of some general anaesthetics than are other synaptic preparations [29] .
We were particularly interested in the decay phase of the EJP as a possible reflection of direct pressure-anaesthetic antagonism. Pressure slows the decay rate of synaptic currents [21] and potentials [24] . None of the anaesthetics significantly changed EJP decay rate in this study. A decrease in decay time constant for postsynaptic currents has been reported at the vertebrate neuromuscular junction for a variety of anaesthetics [30] . Halothane and pentobarbitone have been reported to increase the rate of decay of currents in a crustacean neuromuscular junction, but only at concentrations above the anaesthetic range for man [29] . The crustacean muscle cell is large, with a low resistance cell membrane. It is possible that there is a basic effect of anaesthetics on EJP current decay time constant which is too small to affect the voltage measurements to which the present study was restricted.
Membrane resistance and resting potential did not change significantly or consistently in the present study. Others have reported anaestheticrelated hyperpolarization related to an increase in conductance in vertebrate CNS neurones [31] [32] [33] . The latter have many membrane ion channels which have not been documented as yet in crustacean muscle cells. However, the GABAactivated chloride conductance which has been implicated in some studies as related to the hyperpolarization is present at the inhibitory neuromuscular junction in these cells. Small changes in membrane resting potential, resistance, or both, are not excluded by the results of this study.
Pentobarbitone auto-antagonism: implications for anaesthesia
Pentobarbitone increased tetanic potentiation during a train of stimuli. This is a novel and unexpected finding, although there is a report of possible pentobarbitone-related increases in potentiation in mammalian cortex [34] . The result of this property is that the agent partially antagonizes its own depressant effects on synaptic transmission in the course of the bursts of repetitive activity characteristic of many synapses. Thus, the potency of at least this barbiturate anaesthetic is dependent in part on the normal pattern of activity at a given synapse and the integrative properties of that synapse.
Our results do not permit much speculation on the mechanism of this anaesthetic effect; however, at least one possibility can be excluded. The increase in potentiation seen with pentobarbitone cannot result from a direct effect on presynaptic voltage-dependent sodium channels. Barbiturates, in common with local anaesthetics, block sodium channels in a frequency-dependent manner [35] . Repetitive activity enhances the block, an effect which has been postulated to account for the frequency-dependent block of transmission at the neuromuscular junction observed with the related anticonvulsant, phenytoin [36] . On this basis, action potential amplitude in the presynaptic terminal would tend to be reduced progressively during a train of stimuli. The frequency-dependent effects of barbiturates on the sodium channel would thus act in opposition to the enhancement of potentiation which was actually observed.
BRITISH JOURNAL OF ANAESTHESIA
Relationship of the findings to the mechanism of pressure reversal
Pressure can " reserve " the depressant effect of pentobarbitone at a neuromuscular junction exposed to repetitive activation. The motivation for this study was our previously reported finding that pressure had some potentially excitatory effects at this junction, prolonging the decay of the EJP, increasing paired-pulse facilitation, and increasing potentiation during a train of responses [24] . In no case did any of the anaesthetics act in a direction opposite to pressure with respect to these three variables, with the possible exception of EJP decay rate, as noted above. Anaesthetics exerted no significant depressant effects on paired-pulse facilitation and one, pentobarbitone, acted in the same direction as pressure on potentiation. The mechanism for pressure reversal of the anaesthetic effect at this synapse is therefore an additive interaction rather than an antagonistic one.
There were no significant interactions between pressure and pentobarbitone with respect to effects on EJP amplitude, inhibition or facilitation. The present data thus provide no basis for "true" antagonism between pressure and anaesthetics of the antagonist-agonist type. As with previous studies, the depressant effects of pressure and anaesthetics on synaptic transmission as measured by singly evoked EJP amplitudes are additive [18, 23] . No studies on neuronal systems have provided evidence for a "true" antagonism not based on opposing independent actions. However, it is conceptually possible, and has been shown in a bilayer model [37] .
Potentiation as a mechanism for pressure reversal of anaesthesia
Both pentobarbitone and pressure enhance potentiation, and each antagonizes its own synaptic depressant effect through this mechanism. The frequency-dependent effects of pressure were shown in an early study [20] . Pentobarbitone has been reported to increase potentiation in mammalian cortex [34] . As we have measured potentiation in this study, it includes components of the shorter-term process of facilitation, one or more longer-term processes termed potentiation, and summation.
Summation is a postsynaptic phenomenon, while facilitation and potentiation are predominantly presynaptic. We have shown that pressure enhances facilitation, which is evidence for a presynaptic site of action [24] . The depressant effect of pressure on synaptic transmission results predominantly from depression of transmitter release [21, 38] by an unknown mechanism. Anaesthetics also depress transmitter release [39, 40] by a mechanism which may involve depression of calcium influx [41, 42] . Agents which depress transmitter release, particularly those which do so by blocking or reducing calcium entry, enhance facilitation; in fact, enhancement of facilitation is taken as evidence for a presynaptic site of action [43] . The evidence available thus strongly suggests that both pressure and pentobarbitone enhance potentiation because they both inhibit initial transmitter release. It remains to be determined if they both do so by acting in part on the same process, for example to decrease initial calcium entry.
The increase in potentiation at 10.1 MPa was sufficient to overcome partially the depressant effect of the barbiturate. If this is an important component of pressure reversal of anaesthesia, pressure reversal of anaesthesia does not result from direct antagonism between pressure and anaesthetic actions. The evidence that both pressure and anaesthetic agents act in the same direction on presynaptic processes is presented above. There is evidence that depression of the postsynaptic response accounts for much of the anaesthetic depression of excitatory synaptic transmission [30, 44] . If relief of the depression is a result of actions on presynaptic processes, pressure-anaesthetic antagonism is indirect, at least in large part.
Network properties and the role of inhibition
Pressure depresses GABA-mediated inhibition in this preparation to the same extent as excitation, probably by the same non-selective mechanism of depression of transmitter release [24] . Pressure depression of inhibition does not contribute to an overall increase in excitation, probably because this inhibitory neuromuscular junction also displays prominent facilitation which is enhanced by pressure. In this preparation also, we did not observe pentobarbitone enhancement of inhibition such as has been reported at mammalian synapses [45] . On the other hand, in the mammalian CNS, inhibitory synaptic transmission may play a role in anaesthesia and pressure reversal. There is evidence that, in the hippocampus, inhibition is mediated by tonically active decrementing, rather than facilitating, synapses [46] . The non-selective depressant effect of pressure on inhibition, therefore, might not be counteracted by enhancement of potentiation during repetitive activity. In addition, it has been suggested that glycine rather than GABA is the inhibitory transmitter implicated in pressureinduced seizures [47] . Whether or not inhibition is enhanced by anaesthetics, the combination of facilitating excitatory synapses and non-facilitating inhibitory synapses characterizes a network of which the level of excitation might be readily increased by pressure, by the mechanism we propose. Pressure reversal, rather than defining the molecular site of anaesthetic action, may thus constrain the network integrative properties of the CNS site of anaesthesia.
